TuHURA Biosciences (HURA) Preferred Dividend Payments (2016 - 2026)
TuHURA Biosciences (HURA) posted quarterly Preferred Dividend Payments of $2089.0 for Q1 2026, little changed year-over-year from $2089.0 in Q1 2025, and little changed quarter-over-quarter from $2089.0 in Q4 2025.
TuHURA Biosciences (HURA) Preferred Dividend Payments (2016 - 2026) Analysis & Trends
TuHURA Biosciences' Preferred Dividend Payments history runs 11 years deep, the most recent figure standing at $2089.0 for Q1 2026.
- In Q1 2026, Preferred Dividend Payments changed 0.0% year-over-year to $2089.0; the TTM figure through Mar 2026 stood at $8356.0 (down 40.69% YoY), while the FY2025 annual figure was $8356.0, up 300.0% from the prior year.
- Preferred Dividend Payments for Q1 2026 stood at $2089.0, roughly flat from $2089.0 in the prior quarter.
- The five-year high for Preferred Dividend Payments was $6000.0 in Q1 2024, with the low at $2000.0 in Q1 2022.
- The 5-year median for Preferred Dividend Payments is $2044.5 (2022), against an average of $2460.4.
- The sharpest annual moves came in 2024 and 2025: Preferred Dividend Payments jumped 200.0% in 2024, then sank 65.18% in 2025.
- TuHURA Biosciences' Preferred Dividend Payments stood at $2000.0 in 2022, then surged by 100.0% to $4000.0 in 2023, then slumped by 50.0% to $2000.0 in 2024, then climbed by 4.45% to $2089.0 in 2025, then changed by 0.0% to $2089.0 in 2026.
- Business Quant data shows HURA's Preferred Dividend Payments at $2089.0 in Q1 2026, $2089.0 in Q4 2025, and $2089.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | TuHURA Biosciences | 37.61 Mn | 37.61 Mn | - | 2,089.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,089.00 |
| Dec 31, 2025 | 2,089.00 |
| Sep 30, 2025 | 2,089.00 |
| Jun 30, 2025 | 2,089.00 |
| Mar 31, 2025 | 2,089.00 |
| Sep 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | -3.17 Mn |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 2,000.00 |
| Sep 30, 2020 | 5,000.00 |